Trial Profile

A multi-center, parallel, open-label clinical phase 2a trial designed to deeply explore the effectiveness and safety of MN-08 in patients with hypertension

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 07 May 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

07 May 2024 New trial record
02 Apr 2024 According to a Xique Pharmaceuticals media release, clinical phase 2a trial for the treatment of hypertension has officially started.
02 Apr 2024 According to a Xique Pharmaceuticals media release, Director Wu S gave introduction to MN-08's, drug safety, inclusion and exclusion criteria of the trial in the launch meeting of Phase 2a clinical trial of MN-08 tablets for the treatment of hypertension was successfully held at the First Affiliated Hospital of Jinan University (Huaqiao Hospital). Director Wu Shaorong is the project lead and Principal investigator from Department of Cardiology, the First Affiliated Hospital of Jinan University

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com